| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129463 Quinazolin-4(3A)-One Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129462 Intranasal administration of active agents to the central nervous system |
| 06/02/2011 | US20110129461 Mat II Beta Subunit RNAi and Therapeutic Methods Using Same |
| 06/02/2011 | US20110129457 Variant hhip1 protein and methods and uses thereof |
| 06/02/2011 | US20110129454 Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions |
| 06/02/2011 | US20110129450 Method of promoting neurogenesis by modulating secretase activities |
| 06/02/2011 | US20110129448 Methods to mobilize progenitor/stem cells |
| 06/02/2011 | US20110129445 Combinations comprising methotrexate and dhodh inhibitors |
| 06/02/2011 | US20110129444 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 06/02/2011 | US20110129443 Macrocyclic serine protease inhibitors |
| 06/02/2011 | US20110129442 Lipoic acid pellet composition |
| 06/02/2011 | US20110129441 Method and system to remove soluble tnfr1, tnfr2, and il2 in patients |
| 06/02/2011 | US20110129440 Heterocyclic Urea and Thiourea Derivatives and Methods of Use Thereof |
| 06/02/2011 | US20110129439 Conditioned medium of liver progenitor cells |
| 06/02/2011 | US20110129438 Immunogenic protein constructs |
| 06/02/2011 | US20110129422 Viscous Terpolymers as Drug Delivery Platform |
| 06/02/2011 | US20110129418 Brain Tumor Targeting Peptides and Methods |
| 06/02/2011 | US20110129415 Novel antibody and use in diagnosis and therapy of arthropathies |
| 06/02/2011 | US20110126767 Methods and compositions for increasing the hatchability of hatchery eggs |
| 06/01/2011 | EP2327985A2 T1R Hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds |
| 06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 06/01/2011 | EP2327777A1 Method for immobilising biologically active substances on polymer carriers (variants) and conjugates produced by said method |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327724A2 Modified human growth hormone polypeptides and their uses |
| 06/01/2011 | EP2327722A2 Mammalian genes involved in viral infection and tumor suppression |
| 06/01/2011 | EP2327719A1 Hybrid and tandem expression of neisserial proteins |
| 06/01/2011 | EP2327717A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327716A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327715A1 Replikin peptides and uses thereof |
| 06/01/2011 | EP2327714A1 Prophylactic or therapeutic agent for influenza virus infection |
| 06/01/2011 | EP2327713A1 Metal-binding compounds and uses therefor |
| 06/01/2011 | EP2327712A2 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 06/01/2011 | EP2327451A2 Method for detecting and inhibiting angiogenesis |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327416A1 Pharmacological vitreolysis using truncated plasmin |
| 06/01/2011 | EP2327415A1 Pharmacological vitreolysis using truncated plasmin |
| 06/01/2011 | EP2327414A1 Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme |
| 06/01/2011 | EP2327413A1 Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use |
| 06/01/2011 | EP2327412A1 Treatment of nerve injuries |
| 06/01/2011 | EP2327408A1 Tetracyclic cyclic gmp-specific phosphodiesterase inhibitors for the treatment of benign prostatic hypertrophy |
| 06/01/2011 | EP2327399A1 Treatment of hypertension |
| 06/01/2011 | EP2326670A1 Hetero-multivalent binding agents for members of the tgf superfamily |
| 06/01/2011 | EP2326667A1 Proteic acid polymer, production processes, use of proteic acid polymer, pharmaceutical composition and method of treatment |
| 06/01/2011 | EP2326665A1 Non-cytotoxic fusion proteins comprising egf muteins |
| 06/01/2011 | EP2326662A2 Mutant bacterial glycoproteins and uses thereof |
| 06/01/2011 | EP2326657A1 Synthesis of glatiramer acetate |
| 06/01/2011 | EP2326358A2 Osteogenic compositions containing a coloring agent |
| 06/01/2011 | EP2326343A2 Pancreatic polypeptide and variants thereof for use in the treatment of intestinal disorders |
| 06/01/2011 | EP2326342A1 Methods for using interferon gamma to absorb fluid from the subretinal space |
| 06/01/2011 | EP2326341A2 Peptide formulations and uses thereof |
| 06/01/2011 | EP2326340A2 Compositions and methods for treating s. pneumoniae infection |
| 06/01/2011 | EP2326339A2 Methods for treating progressive cognitive disorders related to neurofibrillary tangles |
| 06/01/2011 | EP2326333A1 Agent for promoting neuronal differentiation and method therefor |
| 06/01/2011 | EP2326182A1 Composition and method to modify sperm fertility and female gender ratio in mammals |
| 06/01/2011 | EP2298336A9 Promotion of epithelial regeneration |
| 06/01/2011 | EP2054439B1 Cd4-receptor-derived peptides and method for the preparation thereof |
| 06/01/2011 | EP1945661B1 Gpr 146 receptor |
| 06/01/2011 | EP1608307B1 An antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same |
| 06/01/2011 | EP1259265B1 Nucleic acid formulations for gene delivery |
| 06/01/2011 | EP1073759B1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 06/01/2011 | CN1876177B Biodegradable material microsphere blood vessel suppository containing liposome cell factor and its preparation and uses |
| 06/01/2011 | CN102083857A Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 06/01/2011 | CN102083855A New insulin analogues of prolonged activity |
| 06/01/2011 | CN102083854A Glycosylated GLP-1 peptide |
| 06/01/2011 | CN102083852A Cyclosporin analogs and their use in the treatment of HCV infections |
| 06/01/2011 | CN102083459A Low viscosity compositions comprising a PEGylated GLA-domain containing protein |
| 06/01/2011 | CN102083458A Super fast-acting insulin compositions |
| 06/01/2011 | CN102083457A Smallpox DNA vaccine and the antigens therein that elicit an immune response |
| 06/01/2011 | CN102083456A Neurodegenerative disorders |
| 06/01/2011 | CN102083455A Regulators of MMP-9 and uses therof |
| 06/01/2011 | CN102083454A Methods of diagnosing, preventing and treating bone mass diseases |
| 06/01/2011 | CN102083453A Anxiolytic composition containing [alpha]s1-casein-derived peptides |
| 06/01/2011 | CN102083452A Compositions and methods for promoting vascular barrier function and treating pulmonary fibrosis |
| 06/01/2011 | CN102083451A Suppression of cancers |
| 06/01/2011 | CN102083450A Assay for pathogenic conformers |
| 06/01/2011 | CN102083441A Use of nifurtimox for treating giardiasis |
| 06/01/2011 | CN102083440A Nifurtimox for treating diseases caused by trichomonadida |
| 06/01/2011 | CN102083435A Telaprevir dosing regimen |
| 06/01/2011 | CN102083433A Treatment of hepatitis c virus infections with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha-2A/2B and ribavirin |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102083399A Treatment of movement disorders by a combined use of botulinum toxin and muscle stimulation |
| 06/01/2011 | CN102080117A Inflammatory factor receptor antagonist of microbial source and preparation method thereof |
| 06/01/2011 | CN102080098A Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation |
| 06/01/2011 | CN102080079A Preparation method and application of novel antimicrobial peptide Misgurin mutant |
| 06/01/2011 | CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof |
| 06/01/2011 | CN102079785A Thymopoietin-II mutant |
| 06/01/2011 | CN102079784A Canine interferon-Alpha mutant |
| 06/01/2011 | CN102079782A Antibacterial peptide used for killing Cryptocaryon irritans and preparation method and applications thereof |
| 06/01/2011 | CN102079780A Construction of recin A chain mutant and application of recin A chain mutant as candidate vaccine antigen |
| 06/01/2011 | CN102079777A Artificially synthesized antimicrobial peptide, preparation method and application thereof |
| 06/01/2011 | CN102078636A Hydrogel dressing containing recombinant human epidermal growth factor and preparation method and application thereof |
| 06/01/2011 | CN102078603A Medicine with action of treating cardiovascular and cerebrovascular diseases |
| 06/01/2011 | CN102078602A Antitumor composite and preparation method thereof |
| 06/01/2011 | CN102078601A Anti-tumor composition and preparation method thereof |
| 06/01/2011 | CN102078600A Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same |
| 06/01/2011 | CN102078599A Compound trimebutine maleate preparation and preparation method thereof |
| 06/01/2011 | CN102078598A Injection for preventing and treating porcine viral diseases and preparation method thereof |
| 06/01/2011 | CN102078597A Methods for treating muscle injuries |